TY - JOUR
KW - Maria Sabina
KW - Psilocybe
KW - Review
KW - Wasson
KW - Biodiversity
KW - bioprospecting
KW - cultural anthropology
KW - depression
KW - drug industry
KW - ethics
KW - human
KW - Indigenous people
KW - indigenous rights
KW - Intellectual property
KW - Knowledge
KW - Law
KW - lifestyle
KW - magic mushrooms
KW - market
KW - patent
KW - patents
KW - priority journal
KW - psilocybin
KW - psilocybine
KW - ritual
AU - Konstantin Gerber
AU - Inti Flores
AU - Angela Ruiz
AU - Ismail Ali
AU - Natalie Ginsberg
AU - Eduardo Schenberg
AB - Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous rights to their intangible cultural heritage.
DO - 10.1021/acsptsci.0c00171
M1 - 2
N1 - Publisher: American Chemical Society
N2 - Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous rights to their intangible cultural heritage.
SP - 573
EP - 577
TI - Ethical Concerns about Psilocybin Intellectual Property
UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100187437&doi=10.1021%2facsptsci.0c00171&partnerID=40&md5=bd61da077bb6c442d705e4431b9b6047
VL - 4
SN - 25759108 (ISSN)
ER -